The IL8-CXCR1/2 axis can modulate the phenotypic status of tumor cells by activating a cellular differentiation program known as epithelial–mesenchymal transition (EMT), which endows tumor cells with enhanced metastatic, stemness, and resistance qualities [26]. Here, CXCR1 is linked to neoplasm.